Status:
COMPLETED
A Cannabis E-intervention for Young Cannabis Users With Early Psychosis (iCC)
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborating Sponsors:
Ministere de la Sante et des Services Sociaux
Conditions:
Cannabis Use Disorder
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
The concerning lack of research related to technology-based psychological interventions in individuals with psychosis and cannabis use disorder (CUD) led to the design a randomized control trial (RCT)...
Detailed Description
This is a multi-site, two-arm, open-label, pilot randomized control trial, involving 100 young adults diagnosed with psychosis and cannabis use disorder (CUD). Participants will be randomly assigned t...
Eligibility Criteria
Inclusion
- Participants must meet all of the following criteria:
- Young adults age 18 to 35 years old
- Diagnosed with any psychotic disorder, which can include schizophrenia, schizoaffective disorder, bipolar disorder with psychotic features, delusional disorder, psychotic disorder not otherwise specified, brief psychotic disorder and substance-induced psychotic disorder.
- Has been followed at an early psychosis clinic for a minimum of 3 months
- Diagnosed with a current CUD (any severity), based on Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria
- Currently using cannabis (used cannabis at least once in the past month)
- Accepting an intervention for CUD to cease or decrease his/her use
- Able to provide full informed consent
- Available for the whole duration of the study/able to comply with study procedures
- Able to comprehend French or English
Exclusion
- Any medical condition that in the opinion of the psychiatrist precludes safe participation in the study or the ability to provide fully informed consent
- Any disabling, unstable or acute mental condition that in the opinion of the psychiatrist precludes safe participation in the study or the ability to provide fully informed consent
- Any legal/judicial status/issue, pending legal action, or other reasons in the opinion of the study team that might prevent completion of the study
- Presence of an additional substance use disorder that, in the opinion of the psychiatrist, precludes safe participation in the study (e.g., very unstable or severe substance use disorder)
- Currently participating in another specific cannabis use-focused intervention (other than those which are part of the intervention and control arms)
Key Trial Info
Start Date :
July 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05310981
Start Date
July 6 2022
End Date
July 31 2024
Last Update
December 23 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Foothills Medical Centre Early Psychosis Intervention Program
Calgary, Alberta, Canada, T2N2T9
2
Nova Scotia Early Psychosis Program
Halifax, Nova Scotia, Canada, B3H2E2
3
Clinic Connec-T - Institut universitaire en santé mentale de Montréal
Montreal, Quebec, Canada, H1N3M5
4
Clinique JAP, Centre hospitalier de l'Université de Montréal
Montreal, Quebec, Canada, H2X 3E4